This week, NVIDIA announced new partnerships with Harvard and MIT’s Broad Institute, bringing cutting-edge analytics tools to the institute’s Terra cloud platform and using it by more than 25,000 life sciences researchers. use it.
WHY IT IMPORTANT
By connecting NVIDIA’s computational tools and artificial intelligence with Broad Institute scientists, the open platform can help advance biomedical research, genomics, and other precision medicine innovations. The aim is to help academic researchers – as well as startups and large pharmaceutical companies – get the AI-powered computing power to mine large amounts of healthcare data.
According to the company, the initial focus will be on several key areas, starting with Parabricks, a GPU-accelerated software suite for secondary analysis of sequence data. NVIDIA says it’s offering it in six new Terra workflows, allowing researchers to analyze the entire genome in over an hour, compared with 24 hours in a CPU-based environment. This can reduce the computational cost significantly.
Another focus will be on building massive models of language, helping researchers develop foundational models for DNA and RNA to better understand human biology. They can use NVIDIA’s BioNeMo technology, a newly announced AI application framework designed for LLM.
NVIDIA is also working on a new deep learning model for the Broad Institute Genome Analysis Toolkit, used by more than 100,000 researchers. It can help detect and identify genetic variants associated with disease, advance drug discovery research, and develop new treatments.
Broad Institute researchers will also have access to MONAI, a deep learning framework focused on medical imaging, and NVIDIA RAPIDS, a set of tools that could enable faster data preparation for cellular analysis single genome.
TREND TO BIGGER WOMAN
The Broad Institute is working to innovate biomedical and precision medicine, building an open cloud platform to connect researchers and provide them with powerful data sets and AI tools for analysis. analyze life science and genomic data to drive scientific breakthroughs.
It is doing this with a number of technology partnerships like the one with NVIDIA. For example, in 2021 it launched a new partnership with Microsoft and Verily to accelerate new advances in biomedicine through the Terra platform.
But the MIT-Harvard research venture is also generous with its own technological innovations. In 2017, the Broad Institute made its GATK genome analysis software open source to make it available to more scientific researchers.
ON PROFILE
Kimberly Powell, NVIDIA’s Vice President of Healthcare, said: “Better computational tools are needed to create breakthroughs in the way we understand disease, develop diagnoses, and deliver provide a treatment”.
“By expanding our partnership with the Broad Institute, we can bring together the power of large language models to ultimately provide common solutions and bridge the gap between insights from researchers and real benefits to patients.”
“Life sciences are in the midst of a data revolution, and researchers are desperately in need of a new approach to bringing machine learning to biomedicine,” added Broad Institute Data Science Director Anthony Philippakis. “In this partnership, we look forward to expanding our mission of sharing data and collaborative processes to scale up genomic research.”
Twitter: @MikeMiliardHITN
Email the writer: [email protected]
Healthcare IT News is a HIMSS publication.
